BRIEF-Ono Pharmaceutical Co., Ltd.- Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean

1

Oct 8 (Reuters) – ONO PHARMACEUTICAL CO., LTD.: * ONO PHARMACEUTICAL CO., LTD.: ONO PHARMA ANNOUNCES AN EXCLUSIVE LICENSE AGREEMENT WITH BIOHAVEN TO DEVELOP AND COMMERCIALIZE IGG DEGRADERS IN JAPAN,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)